Sunday, September 25, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

MADISON, Wisc. - Directors are selling TomoTherapy too cheaply to Accuray and Jaguar Acquisition, for $277 million in a cash and stock deal, shareholders say.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.